Major effects of TPO delivered by a single injection of a recombinant adenovirus on prevention of septicemia and anemia associated with myelosuppression in mice. Risk of sustained expression inducing myelofibrosis due to immunosuppression

Gene Therapy

Volumn 5, Issue 4, 1998, Pages 497-506

  Abina, M A ^a,c,d   Tulliez, M ^b   Lacout, C ^a   Debili, N ^a   Villeval, J L ^a   Pflumio, F ^a   Wendling, F ^a   Vainchenker, W ^a   Haddada, H ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Université Paris Descartes   (France)

^c INSERM   (France)

^d CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Adenovirus vector; Immunosuppression; Myelofibrosis; Myelosuppression; Thrombopoietin

Indexed keywords

THROMBOPOIETIN; VIRUS VECTOR;

ADENOVIRUS; ANEMIA; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW SUPPRESSION; BURST FORMING UNIT E; COLONY FORMING UNIT GM; CONTROLLED STUDY; HYPERPLASIA; IMMUNE DEFICIENCY; MEGAKARYOCYTE; MOUSE; MYELOFIBROSIS; NONHUMAN; PRIORITY JOURNAL; SEPTICEMIA; SPLEEN; THROMBOCYTOSIS; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA;

EID: 0031916263     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300638     Document Type: Article

References (42)

1. Bartley TD et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994; 77: 1117-1124.
2. de Sauvage FJ et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533-538.
3. Lok S et al. Murine thrombopoietin: expression cloning, cDNA sequence and stimulation of platelet production in vivo. Nature 1994; 369: 565-568.
4. Wendling F et al. c-MPL ligand is a humoral regulator of megakaryocytopoiesis. Nature 1994; 369: 571-574.
5. de Sauvage FJ et al. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med 1996; 183: 651-656.
6. Gurney AL, Carver-Moore K, de Sauvage F, Moore MW. Thrombocytopenia in c-mpl-deficient mice. Science 1994; 265: 1445-1447.
7. Debili N et al. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiavive factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 1995; 86: 2516-2525.
8. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995; 86: 419-431.
9. Farese AM, Hunt P, Boone T, MacVittie TJ. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood 1995; 86: 54-59.
10. Kaushansky K et al. Murine thrombopoietin: the ligand for c-mpl expands megakaryocyte progenitors, induces their differentiation and stimulates platelet production. Nature 1994; 369: 568-571.
11. Hokom MM et al. Pegylated megakaryocyte growth and development factor abrogates the lethal thrombopenia associated with carboplatin and irradiation in mice. Blood 1995; 86: 4486-4492.
12. Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995; 85: 2720-2730.
13. Cohen-Solal K et al. Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis. Blood 1996; 88: 2578-2584.
14. Stoffer R, Wiestner A, Skoda RC. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 1996; 87: 567-573.
15. Van X-Q et al. A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. Blood 1996; 88: 402-409.
16. Villeval JL et al. High level of thrombopoietin production by hemopoietic cells induces a fatal myeloproliferative syndrome in mice. Blood 1997; 90: 4369-4383.
17. Ali M, Lemoine NR, Ring CJA. The use of DNA viruses as vectors for gene therapy. Gene Therapy 1994; 1: 367-384.
18. Descamps V et al. Erythropoietin gene transfer and expression in adult normal mice: use of an adenovirus vector. Hum Gene Ther 1994; 5: 979-985.
19. Tripathy SK et al. Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc Natl Acad Sci USA 1994; 91: 11557-11561.
20. Ohwada A, Rafii S, Moore MAS, Crystal RG. In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation- and chemotherapy-induced bone marrow suppression. Blood 1996; 88: 778-784.
21. Villeval J-L et al. Retrovirus-mediated transfer of the erythropoietin gene in hematopoietic cells improve murine beta thalassemia. Blood 1994; 84: 928-933.
22. Yang Y, Ertl HCJ, Wilson JM. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1994; 1: 433-442.
23. Tripathy S, Black HB, Goldwasser E, Leiden JM. Immune response to transgene-encoded proteins limits the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med 1996; 2: 545-550.
24. Michou AI et al. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistance of transgene expression. Gene Therapy 1997; 4: 473-482.
25. Wadsworth SC, Zhou H, Smith AE, Kaplan JM. Adenovirus vector-infected cells can escape adenovirus antigen-specific cytotoxic T-lymphocyte killing in vivo. J Virol 1997; 71: 5189-5196.
26. Yan XQ et al. Chronic exposure to retroviral vector encoded TPO (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood 1995; 86: 4025-4033.
27. Zhou W et al. Transgenic mice overexpressing human c-mpl ligand exhibit chronic thrombocytosis and display enhanced recovery from 5-fluorouracil or anti-platelet serum treatment. Blood 1997; 89: 1551-1559.
28. Ulich TR et al Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice. Blood 1996; 87: 5006-5015.
29. Smith TA et al. Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector. Gene Therapy 1996; 3: 496-502.
30. Lochmuller H et al. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. Gene Therapy 1996; 3: 706-716
31. Yang Y, Greenough K, Wilson JM. Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Therapy 1996; 3: 412-120.
32. Kolls JK et al. Use of transient CD4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors. Hum Gene Ther 1996; 7: 489-497.
33. Konishi H et al. Effective prevention of thrombocytopenia in mice using adenovirus-mediated transfer of hst-1 (fgf4) gene. J Clin Invest 1995; 96: 1125-1130.
34. Kaushansky K et al. Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells in normal and myelosuppressed mice. Exp Hematol 1996; 24: 265-269.
35. +Lin primitive progenitor cells. Blood 1996; 88: 1619-1631.
36. Ginsberg HS et al. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci USA 1991; 88: 1651-1655.
37. Crystal RG et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 1994; 8: 42-51.
38. O'Malley CJ et al. Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. Blood 1996; 88: 3288-3298.
39. Fanucchi M et al. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. New Engl J Med 1997; 336: 404-409.
40. Stratford-Perricaudet LD et al. Evaluation of the transfer and expression in mice of an enzyme encoding gene using a human adenovirus vector. Hum Gene Ther 1990; 1: 241-256.
41. Gough NM et al. Structure and expression of the mRNA for murine granulocyte-macrophage colony-stimulating factor. EMBO J 1985; 4: 645-653. Reference added in proof
42. Abina MA et al. Thrombopoietin (TPO) knock-out phenotype induced by cross-reactive antibodies against TPO following injection of mice with recombinant adenovirus encoding human TPO. J Immunol (in press).